Extended outages If you are facing a multi-day outage during extreme heat, prioritize getting the medication to a refrigerated location
Always inform your healthcare provider of all medications and supplements you are taking
Average body weight reduction: 5 mg weekly: 16.0% reduction (approximately 35 pounds for a 220-pound person) 10 mg weekly: 21.4% reduction (approximately 47 pounds) 15 mg weekly: 22.5% reduction (approximately 50 pounds) Placebo: 2.4% reduction Percentage of participants achieving clinically significant weight loss: 5% or more weight loss: 85% at 5 mg, 89% at 10 mg, 91% at 15 mg 10% or more weight loss: 69% at 5 mg, 78% at 10 mg, 84% at 15 mg 20% or more weight loss: 32% at 5 mg, 49% at 10 mg, 57% at 15 mg Look at those numbers carefully
declares clinical trial support from Eli Lilly and Company and research support from Adipo Therapeutics
For researchers interested in how semaglutide compares to other GLP-1 receptor agonists, our semaglutide vs tirzepatide comparison breaks down the differences in receptor activity, efficacy data, and dosing protocols